SunTrust Upgrades Sarepta Therapeutic (SRPT) to Neutral
Tweet
Share
E-mail
Get Alerts SRPT Hot Sheet
Price: $20.94 --0%
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Rating Summary:
19 Buy, 18 Hold, 6 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 9 | Down: 6 | New: 60
Join SI Premium – FREE
SunTrust Robinson Humphrey upgraded Sarepta Therapeutic (NASDAQ: SRPT) from Reduce to Neutral with a price target of $48.00 (from $4.00).
For an analyst ratings summary and ratings history on Sarepta Therapeutic click here. For more ratings news on Sarepta Therapeutic click here.
Shares of Sarepta Therapeutic closed at $28.15 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BridgeBio Oncology Therapeutics, In (BBOT) PT Lowered to $15 at Stifel
- H.C. Wainwright Reiterates Sell Rating on Sarepta Therapeutics (SRPT)
- SS&C Technologies Holdings, Inc. (SSNC) PT Raised to $101 at UBS on AUM Growth Potential
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
